IDEAYA Biosciences, Inc.
IDYA
$24.12
-$0.88-3.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -49.43% | 145.28% | |||
| Gross Profit | 46.78% | -133.03% | |||
| SG&A Expenses | 23.26% | 12.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -44.16% | 125.94% | |||
| Operating Income | 41.45% | -115.48% | |||
| Income Before Tax | 44.61% | -151.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.61% | -151.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.61% | -151.47% | |||
| EBIT | 41.45% | -115.48% | |||
| EBITDA | 41.64% | -116.49% | |||
| EPS Basic | 45.25% | -148.13% | |||
| Normalized Basic EPS | 53.53% | -192.36% | |||
| EPS Diluted | 45.25% | -148.13% | |||
| Normalized Diluted EPS | 53.53% | -192.36% | |||
| Average Basic Shares Outstanding | 1.16% | 1.34% | |||
| Average Diluted Shares Outstanding | 1.16% | 1.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||